CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-A12B/A Other Registration Statement
- UPLOAD Other SEC-generated Letter
- 8-A12B Other Registration of Securities
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
- REGDEX Other REGDEX
Page 64 of 64 · 1,274 filings